In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The innovation is particularly suited for bone and cartilage repair
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
